Evaluation of bronchodilation from aerosol beta 2 agonists delivered by the Inhal-Aid device to young children.
The Inhal-Aid is a device that combines a reservoir aerosol delivery system, two one-way valves, and an incentive spirometer to assist in the delivery of medication from metered-dose inhalers. It appears to result in bronchodilatory effect that is similar to that obtained from (9) compressed air driven nebulizer. Further data are needed to determine if the therapeutic advantages of an aerosol receiving chamber with metered-dose inhalers are matched by clinically important consequences for the patient with adequate coordination. For the patient unable to utilize metered-dose inhalers because of inability to coordinate inspiration with activation, however, the Inhal-Aid provides an effective means to conveniently deliver clinically important antiasthmatic medication.